Plain-English translation of NCT07922122 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
United States
Sponsor
TryAbility LLC
Collaborators
Niche Biomedical, Inc. dba ANEUVO
Enrollment target
~8 participants
Started
June 2026
Primary completion
July 2027
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sakina Valika, DPT
TryAbility NeuroRecovery Centr
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.